References:
- Chaudhuri ratan k. (2004) pcia conference, guangzhou, china
- Chen TS et al. Efficacy of epigallocatechin-3-gallate and amla (emblica officinalis) extract for the treatment of diabetic-uremic patients. med food. 2011 jul-aug; 14(7-8):718-23
- Nampoothiri SV et al. In vitro antioxidant and inhibitory potential of terminalia bellerica and emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes. Food chem toxicol. 2011 jan; 49(1):125-31.
- Sabu MC ; Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J ethnopharmacol. 2002 jul; 81(2):155-60.
- Akhtar MS et al. Effect of amla fruit (emblica officinalis gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int j food sci nutr. 2011 sep; 62(6):609-16.
- Sampath kumar kp et al. Recent trends in potential traditional Indian herbs - Emblica officinalis and its medicinal importance. Journal of pharmacognosy and phytochemistry, vol. 1 no. 1 2012
- Shukla v et al. Evaluation of antioxidant profile and activity of amalaki (emblica officinalis), spirulina and wheat grass. Indian journal of clinical biochemistry, 2009 / 24 (1) 70-75
- Santhosh J et al. Hypolipidemic activity of phyllanthus emblica linn (amla) & trigonella foenum graecum (fenugreek) combination in hypercholesterolemic subjects – A Prospective, randomised, parallel, open-label, positive controlled study. Asian journal of biochemical and pharmaceutical research issue 1 (vol. 2) feb 2012
- Baliga MS ; Dsouza JJ. Amla(emblica officinalis gaertn), a wonder berry in the treatment and prevention of cancer.eur j cancer prev. 2011 may;20(3):225-39.
- Gopa. B et al. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian J Pharmacol. 2012 Mar-Apr; 44(2): 238–242.
Editor: Dr. Nithin Jayan
Technically Checked by: Lingaraj
